Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial

BACKGROUND: Hypertension is the most common cardiovascular disease in Nigeria and contributes to a large non-communicable disease burden. Our aim was to implement and evaluate a large-scale hypertension treatment and control program, adapted from the Kaiser Permanent Northern California and World He...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldridge, Abigail S., Aluka-Omitiran, Kasarachi, Orji, Ikechukwu A., Shedul, Gabriel L., Ojo, Tunde M., Eze, Helen, Shedul, Grace, Ugwuneji, Eugenia N., Egenti, Nonye B., Okoli, Rosemary C. B., Ale, Boni M., Nwankwo, Ada, Osagie, Samuel, Ye, Jiancheng, Chopra, Aashima, Sanuade, Olutobi A., Tripathi, Priya, Kandula, Namratha R., Hirschhorn, Lisa R., Huffman, Mark D., Ojji, Dike B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344662/
https://www.ncbi.nlm.nih.gov/pubmed/35918703
http://dx.doi.org/10.1186/s43058-022-00328-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344662/
https://www.ncbi.nlm.nih.gov/pubmed/35918703
http://dx.doi.org/10.1186/s43058-022-00328-9

Ejemplares similares